We evaluated the values of integration of pretreatment volumetric ADC analysis with human papillomavirus (HPV) genotyping in prediction of survival and recurrence for women with locally advanced cervical cancer in 82 women following concurrent chemoradiation therapy (CCRT). Independent poor prognostic indicators for OS and DFS by stepwise multivariate analysis, i.e., lower ADC10, advanced T or M stage and high-risk HPV status were composed to generate a novel outcome-predicting model, in which death was found in all the high-risk group patients whiles none of the low-risk group died or recurred during the follow up.
This abstract and the presentation materials are available to members only; a login is required.